Early V/S Delayed Induction of Labour in Patients With Prelabour Rupture of Membranes
NCT ID: NCT07261332
Last Updated: 2025-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
88 participants
INTERVENTIONAL
2025-05-10
2025-10-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
To Compare Sweeping of Membranes Versus Expectant Management for Spontaneous Onset of Labor and Vaginal Delivery.
NCT06949787
Cervical Ripening Before Induction of Labour at Term: a Randomised Comparison of Prostin vs Propess
NCT00545194
Intramuscular vs Rectal Progesterone in Preventing Preterm Labour After Cervical Cerclage
NCT07307092
PeRinatal Outcomes With ACTive Versus Expectant Management of Women With Pre-labor Rupture Of Membranes
NCT05958953
Effect of Progesterone on Latent Phase Prolongation in Patients With Preterm Premature Rupture of Membranes
NCT04807543
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
early induction of labour for PROM
The patients assigned with this arm when presented with PROM were inducted immidiately for labour and no observation was done for 24 hours for spontaneous induction of labour
0.5mg PGE2 gel
In this interventional group patients presenting with PROM will be immediately induced by 0.5mg PGE2 gel. If bishop score will not improve after 6 hours, then application of PGE2 gel will be repeated (maximum 2 doses)
Late induction of Labour in PROM
The patients assigned with this arm were observed for 24 hours for any spontanous induction of labour and then only proceeded with manual induction.
0.5mg PGE2 gel
The patients assigned with this intervention will be observed for 24 hours following which induction will be done using 0.5mg PGE2 gel in posterior fornix of vagina.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
0.5mg PGE2 gel
In this interventional group patients presenting with PROM will be immediately induced by 0.5mg PGE2 gel. If bishop score will not improve after 6 hours, then application of PGE2 gel will be repeated (maximum 2 doses)
0.5mg PGE2 gel
The patients assigned with this intervention will be observed for 24 hours following which induction will be done using 0.5mg PGE2 gel in posterior fornix of vagina.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. gestational age between 37-41 weeks as calculated by last menstrual period date or early dating ultrasoumd
3. Spontaeous PROM as confirmed by history and sterile speculum examination
4. modified bishop score \<6
5. no detectable uterine contractions on admission
6. clear liqour and duration of PROM \<6 hours at admission
Exclusion Criteria
2. patients with features of chorioamnionitis (fever , tachycardia, abdominal tendernessor foul smeeling vaginal discharge
3. maternal medical diseaseincluding prompt delivery or C section like severe preeeclampsia, renal or cardiac disease
4. presence of contraindications to labour such as placenta previa , Vasa previa,previous uterine surgery (e.g myomectomy ) that increases the risk of uterine rupture , previous C section
5. history of antepartum hemorrhage
6. Moderate to severe IUGR as diagnosed on ultrasound and doppler studies
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Laiba Qamar
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Laiba Qamar
Supervisor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hameed Lateef Hospital
Lahore, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
#PLROM225#
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.